Australia's TGA issues safety advisory for the Zostavax vaccine

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-88600-6
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [1] Unsettled Issues of Zostavax Vaccine
    Arroyo, Julio C.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) : 889 - 890
  • [2] Unsettled Issues of Zostavax Vaccine Reply
    Schmader, Kenneth E.
    Levin, Myron J.
    Keay, Susan
    Chan, Ivan S. F.
    Annunziato, Paula W.
    Parrino, Janie
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) : 890 - 890
  • [3] Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults
    Choi, Won Suk
    Choi, Jung-Hyun
    Choi, Jun Yong
    Eom, Joong Sik
    Kim, Sang Il
    Pai, Hyunjoo
    Peck, Kyong Ran
    Sohn, Jang Wook
    Cheong, Hee Jin
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (01) : 13 - 17
  • [4] Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
    Gold, Michael S.
    Buttery, Jim
    McIntyre, Peter
    SEXUAL HEALTH, 2010, 7 (03) : 320 - 324
  • [6] A global perspective on vaccine safety and public health: The global advisory committee on vaccine safety
    Folb, PI
    Bernatowska, E
    Chen, R
    Clemens, J
    Dodoo, ANO
    Ellenberg, SS
    Farrington, P
    John, TJ
    Lambert, PH
    MacDonald, NE
    Miller, E
    Salisbury, D
    Schmitt, HJ
    Siegrist, CA
    Wimalaratne, O
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (11) : 1926 - 1931
  • [7] Vaccine Safety Monitoring in Australia
    不详
    PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 67 - 67